Aralez Bio
PrivateLast Round
Series A
Oct 29, 2024
Total Funding Raised
$32.6M
Company Overview
Aralez Bio is a biotechnology company that develops and manufactures noncanonical amino acids using a proprietary enzymatic platform for pharmaceutical, agricultural, and cosmetic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aralez Bio Comparables
Compare Aralez Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Iris Biotech GmbH | 76% | |
| Allozymes | 74% | |
| Codexis | 71% |
Aralez Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 29, 2024 | ||||
| Grant | Oct 3, 2024 | ||||
| Seed | Aug 22, 2022 | ||||
| Accelerator | May 22, 2019 |
Aralez Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Impact Science | Series A |
| Spero Ventures | Series A |
| Good Growth Capital | Seed, Series A |
| U.S. Department of Health and Human Services | Grant |
| Cyclotron Road | Accelerator |
| Climate Capital | Seed |
| Impact Science Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 43% MoM, from 2.4K to 3.4K.
- Jun 1, 2025
Grew 36% QoQ, from 25 to 34 employees.
Aralez Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aralez Bio's valuation, stock price, and market status.
Is Aralez Bio a public or private company?
Aralez Bio is a private company.
What is the current stock price of Aralez Bio?
Aralez Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Aralez Bio worth (valuation)?
Valuation information for Aralez Bio is not publicly available.
Can I buy Aralez Bio stock?
Aralez Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aralez Bio's last funding round?
Aralez Bio's most recent funding round was Series A on October 29, 2024.
Who are the main investors in Aralez Bio?
Key investors in Aralez Bio include Spero Ventures, Paladin Capital Group.
Will Aralez Bio IPO soon?
No public IPO plans have been announced for Aralez Bio.
How can I track Aralez Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aralez Bio's secondary market activity and sign up for updates.